$8.10
0.02[0.25%]
Last update: 9:30AM Get Real Time Here
Ironwood Pharmaceuticals
(NASDAQ:IRWD)Latest News for Ironwood Pharmaceuticals Stock (NASDAQ:IRWD)
Ironwood Pharmaceuticals Stock (NASDAQ: IRWD)
Categories: All
Thursday, March 28, 2024
Thursday, March 07, 2024
Friday, March 01, 2024
Thursday, February 29, 2024
- Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Feb 29, 2024, 2:00PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Feb 29, 2024, 12:32PM
- Why Is Gastrointestinal Healthcare Focused Ironwood Pharmaceuticals Stock Sinking On Thursday?Vandana Singh - Feb 29, 2024, 11:34AM
- Ironwood Pharmaceuticals shares are trading lower after the company's Phase 3 trial of once-weekly subcutaneous apraglutide did not meet two out of four key secondary endpoints.Benzinga Newsdesk - Feb 29, 2024, 10:45AM
- Nasdaq Gains 100 Points Following PCE DataAvi Kapoor - Feb 29, 2024, 10:40AM
- Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps SurgePiero Cingari - Feb 29, 2024, 9:20AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Feb 29, 2024, 8:07AM
- Ironwood Pharmaceuticals Announced Topline Results From Its Pivotal Phase 3 STARS Trial Of Once-weekly Subcutaneous Apraglutide In Reducing Parenteral Support Dependency In Adult Patients With Short Bowel Syndrome With Intestinal FailureBenzinga Newsdesk - Feb 29, 2024, 6:17AM
Thursday, February 15, 2024
- Top 4 Health Care Stocks You May Want To Dump In FebruaryAvi Kapoor - Feb 15, 2024, 8:15AM
- Ironwood Pharmaceuticals Expects FY24 Sales Between $435M-$455M Vs. 462.82M Estimate; Sees FY24 Adjusted EBITDA Above $150MBenzinga Newsdesk - Feb 15, 2024, 7:13AM
- Ironwood Pharmaceuticals Q4 Sales $117.55M Beat $117.48M Estimate, Generated $35.8M In Cash From Operations In Q4Benzinga Newsdesk - Feb 15, 2024, 7:10AM
- Earnings Scheduled For February 15, 2024Benzinga Insights - Feb 15, 2024, 5:17AM
Wednesday, February 14, 2024
Wednesday, January 17, 2024
Monday, January 08, 2024
- Ironwood Announces Publication In The Lancet Gastroenterology & Hepatology Of New Linaclotide Phase III Data In Children And Adolescents Aged 6-17 Years With Functional ConstipationBenzinga Newsdesk - Jan 8, 2024, 10:59PM
- Ironwood Pharmaceuticals Sees FY24 Linzess U.S. Net Sales Growth Of Low-single digits %, With Revenue Guidance Of $435M-$455M Versus Consensus Of $465.80MBenzinga Newsdesk - Jan 8, 2024, 6:07AM
- Ironwood Pharmaceuticals Maintains FY23 Linzess U.S. Net Sales Growth Of 6%-8%, With Total Revenue Guidance Of $435M-$450M Versus Consensus Of $444.02MBenzinga Newsdesk - Jan 8, 2024, 6:05AM
Thursday, December 14, 2023
- Ironwood Pharmaceuticals shares are trading higher after Wells Fargo initiated coverage on the stock with an Overweight rating and announced a $20 price target.Benzinga Newsdesk - Dec 14, 2023, 11:21AM
- Wells Fargo Initiates Coverage On Ironwood Pharmaceuticals with Overweight Rating, Announces Price Target of $20Benzinga Newsdesk - Dec 14, 2023, 7:39AM
Thursday, November 09, 2023
- Ironwood Pharmaceuticals Reaffirms FY23 Revenue Outlook $435M-$450M Vs. $441.42M EstimateBenzinga Newsdesk - Nov 9, 2023, 7:04AM
- Ironwood Pharmaceuticals Q3 Adj. EPS $0.12 Misses $0.16 Estimate, Sales $113.74M Beat $112.89M EstimateBenzinga Newsdesk - Nov 9, 2023, 7:03AM
- Earnings Scheduled For November 9, 2023Benzinga Insights - Nov 9, 2023, 6:52AM
Thursday, October 05, 2023
Thursday, September 28, 2023
Tuesday, September 19, 2023
- Why Terran Orbital Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Sep 19, 2023, 12:49PM
- Ironwood Pharmaceuticals shares are trading higher following a Form4 filing that showed CFO Sravan Emany bought 36,072 shares at an average price of $8.32 per share.Benzinga Newsdesk - Sep 19, 2023, 12:30PM
- Ironwood Pharmaceuticals SVP Makes $300K Stock PurchaseBenzinga Insights - Sep 19, 2023, 11:03AM
- Orchestra BioMed, Vital Farms And Other Big Stocks Moving Higher On TuesdayLisa Levin - Sep 19, 2023, 10:43AM
Monday, September 11, 2023
Friday, September 08, 2023
Wednesday, September 06, 2023
Wednesday, August 23, 2023
Tuesday, August 22, 2023
Tuesday, August 08, 2023
- Ironwood Pharmaceuticals shares are trading lower after the company reported Q2 financial results and issued FY23 revenue guidance.Benzinga Newsdesk - Aug 8, 2023, 1:07PM
- Ironwood Pharmaceuticals Raises FY23 Revenue Outlook To $435M-$450M (From $420M-$435M) Vs. $427.88M EstimateBenzinga Newsdesk - Aug 8, 2023, 7:22AM
- Ironwood Pharmaceuticals Q2 EPS $(6.71) Not Comparable To $0.25 Estimate, Sales $107.38M Beat $103.71M EstimateBenzinga Newsdesk - Aug 8, 2023, 7:09AM
- Earnings Scheduled For August 8, 2023Benzinga Insights - Aug 8, 2023, 4:48AM
Monday, August 07, 2023
Monday, June 12, 2023
- Ironwood Reports FDA Approval Of New Indication For LINZESS (linaclotide) For Treatment O Functional Constipation In Pediatric Patients Ages 6-17 Years-OldBenzinga Newsdesk - Jun 12, 2023, 4:11PM
- Ironwood Pharmaceuticals Gets FDA Approval Of Linzess For The Treatment Of Functional Constipation In Pediatric Patients 6 To 17 Years Of AgeBenzinga Newsdesk - Jun 12, 2023, 12:27PM
Tuesday, May 23, 2023
Monday, May 22, 2023
- Ironwood Scoops Up Gastrointestinal Diseases Player For $1BVandana Singh - May 22, 2023, 2:06PM
- Why VectivBio Shares Are Surging MondayAdam Eckert - May 22, 2023, 10:12AM
- Benzinga Pro's Top 5 Stocks To Watch For Monday, May 22, 2023: MU, RKT, DLTR, LDOS, IRWDBenzinga Newsdesk - May 22, 2023, 9:02AM
- Ironwood Pharmaceuticals Agrees To Acquire VectivBio For $17/Share In An All-Cash Transaction With An Estimated Aggregate Consideration Of Approximately $1BBenzinga Newsdesk - May 22, 2023, 6:59AM